Navigation Links
Data To Be Presented at ASCO Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer
Date:5/31/2008

reatment of recurrent glioblastoma multiforme (GBM)." Sunday, June 1, 2008 2:00 PM - 6:00 PM CDT.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that dose-limiting toxicities may be experienced in future stages of the trial which will use higher doses of Cotara. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in development, preclinical studies or clinical
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
2. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
3. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
4. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
5. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
6. New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nations Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
7. Eisais Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
8. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
9. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
10. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
11. Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014 Sophia Genetics, ... domaine de l,analyse des données issues du SNG ... de diagnostic in vitro (IVD) du gène CFTR ... la mucoviscidose dans un seul essai SGN. La ... les types de variantes par l,intermédiaire d,un seul ...
(Date:9/30/2014)... 2014  Wrightington, Wigan and ... MDRX ) are delighted to announce WWL,s decision ... health information system. The system will be implemented across ... way WWL delivers healthcare in the future. ... of on-time and on-budget system implementations as well as ...
(Date:9/30/2014)... 2014 This study provides an analysis ... solutions including nuclear imaging informatics, PET imaging informatics, ... assesses the size of the market based on ... projects future growth based on the current drivers ... place in the broader markets for imaging equipment, ...
Breaking Medicine Technology:Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 2Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 3Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 4Analysis of the US Molecular Imaging Informatics Market 2Analysis of the US Molecular Imaging Informatics Market 3
... 10, 2010 The American Council on Exercise (ACE), ... fitness certification, education and training organization in the world, ... will focus on eliminating obesity in America.  As an ... the critical need to regularly engage in physical activity ...
... 2010 Luminex Corporation (Nasdaq: LMNX ... the Stephens Fall Investment Conference to be held ... (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) (Logo:   ... Patrick J. Balthrop, president and chief executive officer, ...
Cached Medicine Technology:American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America 2American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America 3Luminex Corporation to Present at Stephens Fall Investment Conference 2
(Date:10/1/2014)... Today marks the final day prosthodontist Dr. ... Oxnard and Woodland Hills, Calif., is in the southern ... , “Speaking to this group of specialists allows more ... the help and care they deserve,” Dr. Jivraj said. ... work, providing cosmetic dentistry, correcting bite issues, placing implants, ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Generic drug ... retail generics increasing in price in the last 12 ... Inc.’s (AIS) Drug Benefit News (DBN) interviewed a plan ... means for pharmacies and health plans. , “When ... rising generic acquisition costs, these cost increases squeeze pharmacies’ ...
(Date:10/1/2014)... October 01, 2014 UP4 Probiotics will ... WOMEN’S probiotic to The National Network to End Domestic ... This organization was chosen through nationwide polling that took ... social media outlets. , “We are proud to ... portion of every sale of UP4 Women’s Probiotics during ...
(Date:10/1/2014)... 2014 Long-acting insulin is safer and more ... 1 diabetes, according to new research published in ... at once-daily and twice-daily doses of both long- ... cost-effectiveness. , "In patients with Type 1 ... to intermediate-acting insulin when it came to controlling ...
(Date:10/1/2014)... 2014 This weekend Pope Francis drew world-wide ... Speaking to 40,000 seniors in St. Peter's Square in ... elderly. "Violence against the elderly is as inhuman as ... are old people just discarded, victims of an abandonment that ... a throw-away culture that is hurting our world so much," ...
Breaking Medicine News(10 mins):Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 3Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 4Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 5Health News:Rising Generic Drug Prices Affect Pharmacies, Insurers Alike, Reports AIS Newsletter 2Health News:Rising Generic Drug Prices Affect Pharmacies, Insurers Alike, Reports AIS Newsletter 3Health News:UP4 Probiotics Partners with The National Network to End Domestic Violence 2Health News:Long-acting insulin is safer, more effective for patients with Type 1 diabetes 2Health News:Pope Francis Shines New Spotlight on Neglect of Elderly, Survey Finds Elder Self-Neglect is a Growing and Hidden Problem in U.S. says NAPGCM 2Health News:Pope Francis Shines New Spotlight on Neglect of Elderly, Survey Finds Elder Self-Neglect is a Growing and Hidden Problem in U.S. says NAPGCM 3
... software medication solution reduces complexity in, patient-specific medication ... ... LAS VEGAS, ASHP, Dec. 3 Ushering in ... OMCL ) a leading provider,of system solutions ...
... with Centers of Influence, POWAY, Calif., Dec. ... leading provider of medical diagnostic imaging systems,and services ... the signing of a letter of agreement with ... of the agreement, the fifth since the inception ...
... advertisements are appearing on television, the bulk of ... spend annually to market their products is targeted ... students. , A literature review by researchers ... the Regenstrief Institute, Inc. published in the December ...
... , , MONDAY, Dec. 3 (HealthDay News) -- Avandia, a ... bone loss, according to a new study conducted in mice. ... may speed osteoporosis, the thinning of the bones that can ... appear in the Dec. 2 online issue of Nature ...
... ANGELES, Dec. 2 Hurricane Katrina was one ... and was the costliest (at an,estimated $86 billion.) ... in the aftermath. Witnessing the,destruction/displacement from the West ... to take his new school training techniques, with,old ...
... Everything from Christmas trees to fake snow can trigger symptoms, ... It,s easy for the holidays to become the season ... or other allergies and asthma, say experts at the American ... preventive measures can cut symptoms to a minimum, they say. ...
Cached Medicine News:Health News:Omnicell Debuts Industry's First Total Automated Patient-Specific Management Solution 2Health News:Omnicell Debuts Industry's First Total Automated Patient-Specific Management Solution 3Health News:Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement 2Health News:Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement 3Health News:Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement 4Health News:Do medical schools affect the way future doctors interact with drug companies? 2Health News:Diabetes Drug Avandia Could Weaken Bones 2Health News:CJ Transforms His Functional Fitness Program Into an Additional Resource for the Hurricane Katrina Survivors 2Health News:CJ Transforms His Functional Fitness Program Into an Additional Resource for the Hurricane Katrina Survivors 3Health News:'Tis the Season For Allergy, Asthma 2
... Millipore has developed a range of ... match specific water quality requirements. Each ... is designed to specifically target contaminants ... HPLC, molecular biology and ICP-MS. The ...
Adjustable speed vortex with inter-changeable heads , 110 V...
Inquire...
Adjustable speed vortex with inter-changeable heads, 110 V...
Medicine Products: